Business Context and Reporting Period
This Form 6-K filing by Banco Santander (Brasil) S.A. serves as a Call Notice and Management Proposal for an Extraordinary General Meeting (EGM) scheduled for October 16, 2025. The filing outlines corporate governance matters, specifically amendments to the Company's Bylaws and changes to the composition of the Board of Directors. The document does not contain financial results for the period ending September 30, 2025.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity for the reporting period. The document is strictly focused on corporate governance and shareholder meeting logistics.
However, the following capital structure details are provided in the Bylaws section:
- Authorized Share Capital: BRL 65,000,000,000.00 (Sixty-five billion Brazilian Reais).
- Total Shares: 7,498,531,051 shares.
- Common Shares: 3,818,695,031.
- Preferred Shares: 3,679,836,020 (entitled to dividends 10% higher than common shares).
- Capital Increase Authorization: The Board is authorized to increase share capital by up to 9,090,909,090 shares without a bylaw amendment.
Material Changes and Governance Proposals
The EGM agenda proposes the following material changes to the Company's governance structure:
- Bylaw Amendments:
- Audit Committee Term: Adaptation to CMN Resolution No. 4,910/21, limiting reappointment to 4 consecutive times (totaling 5 terms of 1 year) to clarify maximum permanence.
- Board Size: Increase the maximum number of Board of Directors members from 12 to 15 to provide greater flexibility.
- Entity Name Update: Update references from "BM&FBOVESPA" to "B3 S.A. – Brasil, Bolsa, Balcão" across multiple articles.
- Board Composition:
- Fix the number of Board members at 12 for the current term.
- Election of New Director: Election of Gilson Finkelsztain (CEO of B3) to the Board for a supplementary term until the 2027 Ordinary General Meeting.
- Confirmation: Confirmation of the full Board composition, noting that Mr. Finkelsztain's term is pending approval from the Brazilian Central Bank.
Outlook, Risks, and Contingencies
Management Commentary: The Board emphasizes that the proposed changes aim to ensure regulatory compliance (specifically regarding the Audit Committee) and operational flexibility. The election of Mr. Finkelsztain is justified by his extensive experience in international financial institutions and his current role as CEO of B3.
Risks and Contingencies:
- Regulatory Approval: The appointment of the new director is contingent upon approval by the Brazilian Central Bank.
- Dispute Resolution: The Bylaws mandate that all disputes between the Bank, shareholders, and management be resolved via arbitration at the Market Arbitration Chamber of B3 S.A.
- Control Transfer: Strict provisions exist regarding the disposal of control, requiring a public offering to minority shareholders at the same price as the controlling shareholder receives.
Investor Verification Checklist
- Verify the remote voting deadline of October 13, 2025, to ensure participation in the EGM.
- Confirm the regulatory approval status of Gilson Finkelsztain's appointment with the Brazilian Central Bank.
- Review the consolidated Bylaws (Exhibit III) to understand the updated Audit Committee term limits and Board size flexibility.
- Check the share capital structure to confirm the ratio of common to preferred shares and the 10% dividend premium for preferred shareholders.
- Monitor the 2027 Ordinary General Meeting timeline, as the current Board term and the new director's term are fixed until that date.